Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils
- PMID: 28494242
- PMCID: PMC5478421
- DOI: 10.1016/j.chom.2017.04.001
Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils
Abstract
Neutrophils are the first line of defense against bacterial infections, and the generation of reactive oxygen species is a key part of their arsenal. Pathogens use detoxification systems to avoid the bactericidal effects of reactive oxygen species. Here we demonstrate that the Gram-negative pathogen Pseudomonas aeruginosa is susceptible to reactive oxygen species but actively blocks the reactive oxygen species burst using two type III secreted effector proteins, ExoS and ExoT. ExoS ADP-ribosylates Ras and prevents it from interacting with and activating phosphoinositol-3-kinase (PI3K), which is required to stimulate the phagocytic NADPH-oxidase that generates reactive oxygen species. ExoT also affects PI3K signaling via its ADP-ribosyltransferase activity but does not act directly on Ras. A non-ribosylatable version of Ras restores reactive oxygen species production and results in increased bacterial killing. These findings demonstrate that subversion of the host innate immune response requires ExoS-mediated ADP-ribosylation of Ras in neutrophils.
Keywords: T3SS; effector function; keratitis; type III secretion.
Copyright © 2017 Elsevier Inc. All rights reserved.
Figures




References
-
- Andersson K, Carballeira N, Magnusson KE, Persson C, Stendahl O, Wolf-Watz H, Fallman M. YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis. Molecular microbiology. 1996;20:1057–1069. - PubMed
-
- Aussel L, Zhao W, Hebrard M, Guilhon AA, Viala JP, Henri S, Chasson L, Gorvel JP, Barras F, Meresse S. Salmonella detoxifying enzymes are sufficient to cope with the host oxidative burst. Molecular microbiology. 2011;80:628–640. - PubMed
-
- Barbieri JT, Sun J. Pseudomonas aeruginosa ExoS and ExoT. Reviews of physiology, biochemistry and pharmacology. 2004;152:79–92. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases